Answers are grounded in this paper and cite their sources.
Coronavirus infection COVID-19 is an infectious disease that can occur in acute, subacute and long-term forms. Long-term coronavirus infection (Long-COVID, post-COVID-19 syndrome) can bring delayed consequences for the patient’s body from various organs and systems. Neurological, psychoemotional, cardiovascular complications of COVID-19 are known. The pathological effect of coronavirus infection on the musculoskeletal system, including skeletal muscles, is of interest. In addition, obesity may develop, including in combination with sarcopenia - sarcopenic obesity. The destructive effect of the SARS-CoV-2 coronavirus on muscle and adipose tissue is complex and multifactorial, and can occur both in the acute and subacute period of COVID-19, and against the background of Long-COVID. The pathological continuum involves hyperproduction of cytokines (called a “cytokine storm” in the acute period of severe coronavirus infection), neuromuscular transmission disorders, increased catabolism, forced physical inactivity, the consequences of self-isolation, and a number of other factors. The relationship between various pathogenic mechanisms of COVID-19 and their impact on muscle and adipose tissue is discussed in this literature review.
No takes yet. Share an insight, caveat, or question.
Kurmaev et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: